Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
Date
News Topics
- (-) Biotechnology (1)
- 3-D Printing/Advanced Manufacturing (26)
- Advanced Reactors (2)
- Artificial Intelligence (8)
- Big Data (2)
- Bioenergy (7)
- Biology (6)
- Biomedical (12)
- Buildings (1)
- Chemical Sciences (3)
- Clean Water (2)
- Climate Change (1)
- Composites (4)
- Computer Science (14)
- Coronavirus (8)
- Cybersecurity (2)
- Decarbonization (3)
- Energy Storage (8)
- Environment (9)
- Fossil Energy (1)
- Frontier (2)
- Fusion (2)
- Grid (1)
- High-Performance Computing (3)
- Machine Learning (5)
- Materials (20)
- Materials Science (28)
- Mathematics (1)
- Microscopy (3)
- Nanotechnology (10)
- National Security (2)
- Neutron Science (101)
- Nuclear Energy (5)
- Physics (9)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (2)
- Simulation (1)
- Space Exploration (4)
- Summit (6)
- Sustainable Energy (8)
- Transformational Challenge Reactor (1)
- Transportation (5)
Media Contacts
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.